(Q50748859)

18 March 2018

title

Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System. (English)

1 reference

18 March 2018

0 references

0 references

6

1 reference

18 March 2018

author name string

Tamra E Meyer

1

1 reference

18 March 2018

Lockwood G Taylor

2

1 reference

18 March 2018

Suji Xie

3

1 reference

18 March 2018

David J Graham

4

1 reference

18 March 2018

Andrew D Mosholder

5

1 reference

18 March 2018

David Moeny

7

1 reference

18 March 2018

Rita P Ouellet-Hellstrom

8

1 reference

18 March 2018

Trinka S Coster

9

1 reference

18 March 2018

language of work or name

English

0 references

publication date

18 October 2012

1 reference

18 March 2018

published in

Addiction

1 reference

18 March 2018

volume

108

1 reference

18 March 2018

issue

1

1 reference

18 March 2018

page(s)

203-210

1 reference

18 March 2018

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Nicotine receptor partial agonists for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Smoking outcome by psychiatric history after behavioral and varenicline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Mental health stability in veterans with posttraumatic stress disorder receiving varenicline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Confounding control in healthcare database research: challenges and potential approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Variable selection for propensity score models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2012.04024.X

10.1111/J.1360-0443.2012.04024.X

21 January 2018

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018